State pharmaceutical assistance programs and how they work with Medicare Part D

Massachusetts stopped accepting new applications to Prescription Advantage, its state drug-cost program for older and disabled residents, after September 11, 2026. The notice on the state's program page¹ is two sentences long, and the second one says that people already enrolled will keep their membership.

Prescription Advantage is one of a shrinking set of state pharmaceutical assistance programs, or SPAPs. New York's version, the Elderly Pharmaceutical Insurance Coverage program, says it helps more than 325,000 income-eligible seniors² pay what is left after their Medicare drug plan has paid. New Jersey and Pennsylvania run similar programs with their own income limits and copays.

These programs sit in an awkward spot. Part D began paying for outpatient prescriptions on January 1, 2006, as New Jersey's program page¹² reminds its readers, and the state programs have had to fit around it ever since, including after the federal out-of-pocket cap arrived in 2025. This piece explains how federal law defines an SPAP, how one coordinates with a Part D plan at the pharmacy counter, and what four states offer in 2026.

How federal law defines a state program

The definition comes from the Medicare Modernization Act of 2003, which added section 1860D-23 to the Social Security Act on December 8, 2003. Under that section, codified at 42 U.S.C. 1395w-133⁵, a State Pharmaceutical Assistance Program is a state program that provides financial help with supplemental drug coverage for people eligible for Part D, and that "does not discriminate based upon the part D plan in which the individual is enrolled." The same section says Part D stays the primary payer and allows a plan's member card to carry an emblem showing the state benefit.

CMS's regulation adds conditions. Under 42 CFR 423.464(e)⁶, a qualifying program must base eligibility "on financial need, age, or medical condition, and not based on current or former employment status," and the definition excludes state Medicaid programs, section 1115 demonstrations and any program funded from federal sources. A retiree drug plan run by a state for its former employees does not count, however generous it is.

Medicare itself describes the programs only loosely. The 2027 edition of the Medicare & You handbook¹⁰ says "many states" have them and directs readers to a state-by-state lookup at go.Medicare.gov/spap or to 1-800-MEDICARE. There is no single federal count of Part D-coordinating SPAPs on a static public page. The closest published list is a different one. CMS keeps a roster of state programs that drug manufacturers may exclude when they calculate Medicaid best price, and its August 2023 version¹¹ lists 44 programs in 19 states. That list mixes senior drug programs with kidney disease, HIV and mental health programs, so it overstates the number of senior wraparound plans.

How a state program coordinates with a Part D plan

At the pharmacy, the Part D plan pays first. The pharmacy then sends a second claim for the remaining cost-sharing to the state program or its processor, and the member pays the state's copay. CMS's Part D coordination-of-benefits manual, chapter 14⁸, lists four ways a state may wrap its benefit around Part D: paying premiums, paying secondary claims at the point of sale, contracting with plans on a lump-sum per-capita basis, or some combination.

One feature matters more than the rest. Payments by a qualified SPAP count toward the Part D out-of-pocket threshold as if the member had paid them. The statute says so in subsection (c)(4)⁵, and the CMS manual calls qualified SPAPs "unique among other payers" for that reason. Payments by non-qualified programs do not count. For 2026, CMS set the standard Part D deductible at $615 and the out-of-pocket threshold at $2,100, according to its 2026 rate announcement⁹. A state program's spending therefore moves a member toward the cap faster than a manufacturer coupon or a non-qualified charity would. Our explainer on Part D changes in 2025, 2026 and 2027 covers the cap itself.

Membership also opens an enrollment window. Under 42 CFR 423.38(c)(17)⁷, a person who belongs to a qualified SPAP gets a special enrollment period allowing one Part D election per year, and keeps it for two calendar months after losing SPAP eligibility. The CMS manual separately bars a state from steering members toward particular plans, and it says a state "may offer a benefit package to eligible beneficiaries that is more than Part D, but cannot be less."

What four states offer in 2026

The state programs differ in who qualifies, what members pay and whether the state covers the Part D premium. The table below uses each state's own published figures.

Sources: New York's 2026 EPIC program highlights³ and copayment schedule⁴; New Jersey's PAAD page¹²; Pennsylvania's PACE and PACENET eligibility page¹³; the Massachusetts program page linked above.

EPIC's copay scale is tied to cost. A prescription whose remaining cost after Part D is $15 or less carries a $3 copay; one costing more than $55 carries $20, according to the state⁴. EPIC also covers some drugs that Part D excludes by law, and it waives its annual fee for members who get full Extra Help from Medicare.

Pennsylvania's programs have an unusual funding source. The state says PACE, PACENET and a related referral service are paid for by the Pennsylvania Lottery¹⁴, and its eligibility page notes that PACENET's income limits rose by $6,000 in February 2022.

Where generics fit in

For the cheapest generics, the state copay can exceed what the pharmacy paid for the drug. GxRadar's analysis of CMS's National Average Drug Acquisition Cost survey¹⁶ puts pharmacy acquisition cost in October 2026 at about 85 cents for 30 tablets of atorvastatin 20 mg (2.8 cents each), 54 cents for 30 tablets of lisinopril 10 mg and 44 cents for 30 tablets of metformin 500 mg. Those are acquisition costs, not counter prices, and a pharmacy's claim also includes a dispensing fee. They explain why the value of a state wraparound for a generic-only regimen often lies in premium help, deductibles and the out-of-pocket count rather than in the per-fill copay. Our guide to what NADAC measures explains the benchmark, and how Part D pays for generics covers the plan side.

Whether a state program, Extra Help, a Medicare Savings Program or a manufacturer assistance program fits a particular person is a question for the state program, a State Health Insurance Assistance Program counselor or a pharmacist. Medicare's own Extra Help page¹⁵ notes that people can apply for Extra Help and a Medicare Savings Program at the same time.

What changes in 2027

Medicare's handbook for next year says the Part D out-of-pocket cap rises to $2,400 in 2027 and that a plan's drug deductible will be no more than $700, according to Medicare & You 2027¹⁰. Open enrollment for 2027 coverage runs October 15 through December 7. State programs that pay premiums or wrap around cost-sharing will reset their own figures for the new year, and New York's program says its annual highlights document is where each year's fee and deductible schedules appear. Readers comparing Part D plan choices can find more on our pharmacy counter desk.